Zobrazeno 1 - 10
of 103
pro vyhledávání: '"Marion Blank"'
Publikováno v:
Journal of the American Academy of Child & Adolescent Psychiatry. 59:1198-1200
The recent Translations article by Bishop et al.1 draws much-needed attention to social communication (SC) in autism spectrum disorder (ASD) and to the need in autism research for treatment-sensitive measures of this key domain. In this context, the
Autor:
Silvio Danese, V. Yajnik, P. Gionchetti, Brian G. Feagan, Richard N. Fedorak, O. Dewit, D. Sorrentino, V. F. Annese, W J Sandborn, Michael Chiorean, G. Radford-Smith, S Plevy, I. Lawrance, Jane E. Onken, Simon Campbell, Jewel Johanns, Peter L. Lakatos, G R D’Haens, Denis Franchimont, J. C. Preiss, Giovanni Terrosu, Áron Vincze, Torsten Kucharzik, Charles Randall, I. Stein, Edward V. Loftus, L. Sauberman, X. Li, I. Oikonomou, Frank Zerbib, H. G. Lamprecht, R. Kottoor, J. Vecchio, Severine Vermeire, Daniel Rachmilewitz, J. R. Lachance, J.L. Dupas, W. H. Holderman, Michael Safdi, T. Haas, J.-F. Colombel, Richard B. Gearry, Russell S. Walmsley, R. P. Phillips, Miguel Regueiro, A. B. Hawthorne, David T. Rubin, J. W. Hamilton, G. D'Haens, M Parkes, Jean-Marie Reimund, Fabrizio Bossa, Walter Reinisch, K. A. Peterson, M. Ropeleski, S. Fishman, Marc Chevrier, Hans H Herfarth, Stephen B. Hanauer, Timothy H. Florin, Walter Fries, D. J. Hetzel, D. E. Elliott, János Banai, B. W. Behm, S. Sedghi, Remo Panaccione, Peter D.R. Higgins, Jean-Paul Achkar, Ziad Younes, Raja Atreya, Harald Vogelsang, M. Noar, S. S. Dhalla, U. Boecker, Raymond Bourdages, Ellen Scherl, Eran Goldin, T. Ritter, S. Gassner, Stefanie Howaldt, M. Ricci, Paolo Gionchetti, B. I. Leman, Marion Blank, D. Grunkmeier, Livia Biancone, J. Mudter, N. Chiba, Paolo Usai, R. Hardi, I. P. Beales, István Altorjay, W. J S Devilliers, J. Hill, Daniel C. Baumgart, Jason M. Swoger, Charles A. Sninsky, B. Singh Salh, L. D. Wruble, G. Bramkamp, Dario Sorrentino, Paul Rutgeerts, Stephen J. Bickston, S. Schreiber, D. J. Helper, Eric Lerebours, Jaroslaw Regula, M. D. Kreines, M. Strasser, C. Antoni, Giovanni Maconi, Freddy Cornillie, Laurent Peyrin-Biroulet, J. S. Hanson, Ewa Małecka-Panas, David Rowbotham, Jean-Charles Grimaud, Gerald Fraser, Ursula Seidler, C. Bünning, C. Berg, G. Reicht, Martin Lukas, John W. Popp, Edouard Louis, D. Laharie, Xavier Hébuterne, K. J. Brown, Márta Varga, L. Paradowski, Robert Ehehalt, Sandro Ardizzone, Stephanie Viennot, S. B. Hanauer, Charles N. Bernstein, Milan Lukas, H. Debinski, R. P. Schwarz, Simon Travis, D. I. Weinberg, D. Wallace, R. S. Stubbs, Bin Zou, A. Sloss, John Wyeth, Irit Avni-Biron, Peter Bossuyt, Ira Shafran, Matthieu Allez, Pierre Desreumaux, Michael Schultz, W. Reinisch, William J. Sandborn
Publikováno v:
Gastroenterology, 150(7), 1568-1578. W.B. Saunders Ltd
Gastroenterology, Vol. 150, no. 7, p. 1568-1578 (2016)
Gastroenterology, Vol. 150, no. 7, p. 1568-1578 (2016)
Background & Aims Most patients with Crohn's disease (CD) eventually require an intestinal resection. However, CD frequently recurs after resection. We performed a randomized trial to compare the ability of infliximab vs placebo to prevent CD recurre
Autor:
Theo Rispens, Gopi Shankar, Dörte Hamann, Kelly Chun, Shawn Black, Freddy Cornillie, Marion Blank, Joseph C. Marini, John W. Popp, Lina Therien, Jocelyn Sendecki, Thomas Van Stappen, Ann Gils
Publikováno v:
AAPS journal, 19(1), 161-171. Springer New York
Monitoring infliximab (IFX) concentrations and antibodies-to-IFX (ATI) titers during inflammatory bowel disease treatment may allow more informed decisions in assessing exposure/response and determining appropriate dosing. To aid in interpreting resu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e8733564947e431ee75bf9f5b750d94
https://pure.amc.nl/en/publications/comparisons-of-serum-infliximab-and-antibodiestoinfliximab-tests-used-in-inflammatory-bowel-disease-clinical-trials-of-remicade(af8dc00c-86eb-48da-857a-04153130e125).html
https://pure.amc.nl/en/publications/comparisons-of-serum-infliximab-and-antibodiestoinfliximab-tests-used-in-inflammatory-bowel-disease-clinical-trials-of-remicade(af8dc00c-86eb-48da-857a-04153130e125).html
Autor:
Jennifer Montello, Freddy Cornillie, Paul Rutgeerts, Robert H. Diamond, William J. Sandborn, Marion Blank, Gary R. Lichtenstein, Linda Tang, Bruce E. Sands, Jean-Frederic Colombel
Publikováno v:
The American Journal of Gastroenterology
OBJECTIVES: The objective of this study was to analyze the safety of long-term infliximab treatment, with/without concomitant immunomodulators, across Crohn's disease (CD) and ulcerative colitis (UC) clinical trials. METHODS: To maximize sample size,
Autor:
Willem J.S. de Villiers, Jewel Johanns, Paul Rutgeerts, Yinghua Lang, Daniel Rachmilewitz, Stephen B. Hanauer, Gary R. Lichtenstein, William J. Sandborn, Bruce E. Sands, Jean-Frederic Colombel, Walter Reinisch, Daniel H. Present, Marion Blank, Brian G. Feagan
Publikováno v:
Inflammatory Bowel Diseases. 18:201-211
Background: The aim was to evaluate long-term efficacy, quality of life, and safety in ulcerative colitis patients who received infliximab during the ACT-1 and -2 extension studies. Methods: Adults with moderate-to-severely active ulcerative colitis
Publikováno v:
Clinical Therapeutics. 33:946-964
Background Infliximab is a chimeric monoclonal antibody against TNFα. The pharmacokinetic (PK) properties of infliximab have been studied in several adult patient populations, but a literature search identified no reported comparative population PK
Autor:
Jewel Johanns, Harland S. Winter, Anne M. Griffiths, G. D. Ferry, Wallace Crandall, Subra Kugathasan, T Walters, Stanley N. Cohen, James Markowitz, Yinghua Lang, Marion Blank, Jeffrey S. Hyams, Gigi Veereman-Wauters, Robert N. Baldassano
Publikováno v:
Current Medical Research and Opinion. 27:651-662
Assess long-term effects of maintenance infliximab therapy in children with moderately-to-severely active Crohn's disease.One hundred twelve patients with a Pediatric Crohn's Disease Activity Index (PCDAI) score30 received infliximab 5 mg/kg at weeks
Publikováno v:
Topics in Language Disorders. 30:308-322
Academic success depends heavily on students’ ability to acquire information, but expository texts are difficult to process and comprehend, particularly for students with language difficulties. Support can be provided through instructional discours
Publikováno v:
Clinical Gastroenterology and Hepatology. 2:912-920
Background & Aims: The ACCENT II study (A Crohn's Disease Clinical Trial Evaluating Infiximab in a New Long-term Treatment Regimen in Patients With Fistulizing Crohn's Disease) evaluated the efficacy and safety of infliximab maintenance treatment in
Autor:
Michael J. Rogers, Marion Blank, J Pesonen, Markku Taskinen, Jukka Mönkkönen, Roger J. Phipps, S. Suri
Publikováno v:
Bone. 29:336-343
Bisphosphonates have become an important addition to the pharmacological armamentarium against postmenopausal osteoporosis. One of the major side effects of oral therapy with some nitrogen-containing bisphosphonates appears to be gastrointestinal (GI